ArticleAnnals of medicine and surgery (2012)2025
Olezarsen: FDA approval and clinical impact in familial chylomicronemia syndrome (FCS).
Muhammad Saad Khan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it